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Background: Atrial fibrillation (AF) significantly increases the risk of stroke and disease
burden; it is an established predictor of poor outcomes after stroke. However, reported
differences in outcomes after stroke among elderly patients between AF and non-AF
group are conflicting. We aimed to compare differences in outcomes at 1 year and 3
years after stroke among elderly patients (aged ≥ 75 years old) between AF group and
non-AF group.
Methods: We recruited 1070 consecutive elderly patients who experienced acute
ischemic stroke between January 2008 and December 2013 in Jiamusi University First
Hospital, China in this study. Information regarding stroke subtype, severity, risk factors,
and outcome (mortality, dependency, and recurrence) at 3 and 12 months after stroke
were recorded and assessed between AF group and non-AF group.
Results: The prevalence of AF was 16.1% overall, with a similar trend in the prevalence
of AF between men and women. The AF group were more likely to experience severe
stroke compared to the non-AF group (32.0 vs. 11.9%, respectively; P < 0.001). There
were no obvious differences between groups regarding the prevalence of hypertension,
dyslipidemia, obesity, current smoking, and alcohol drinking but there was a higher
prevalence of diabetes in the non-AF group (20.3 vs. 30.1%, P = 0.010). Mortality and
dependency rates were significantly higher in the AF group than in the non-AF group at
1 year after stroke (29.6 vs. 17.8%, P = 0.001 for mortality; and 59.5 vs. 36.1%, P =
0.010 for dependency) and 3 years after stroke (46.1 vs. 33.2%, P = 0.032 for mortality;
and 70.7 vs. 49.2%, P = 0.010 for dependency); however, there was no significant
between-groups differences in rates of recurrence across the follow-up periods. The
results for dependency remained stable after adjustment for sex, stroke severity, and
stroke risk factors at 3 years after stroke (OR, 2.26; 95% CI, 1.06–4.81; P = 0.034);
however, the relationship between AF and mortality and recurrence disappeared after
adjusting for these covariates
Conclusion: These findings suggest that it is crucial to highlight the treatment of elderly
stroke patients with AF in order to reduce poor outcomes among the elderly and to
reduce the burden of AF in China.
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INTRODUCTION
Stroke was the second most common cause of death and the
third most common cause of reduced disability-adjusted life-
years (DALYs) worldwide in 2010 (Lozano et al., 2012). Stroke
incidence has declined in industrialized countries over the last 30
years, but it has recently become the leading cause of death in
rural areas and the third cause of death in urban areas in China
(Lloyd-Jones et al., 2009, 2010; Redon et al., 2011; The Ministry
of Health of the People’s Republic of China, 2011).
Atrial fibrillation (AF) is the most common sustained cardiac
arrhythmia. It is an independent risk factor for stroke and is
associated with marked morbidity, mortality, and socioeconomic
burden (Wolf et al., 1991, 1998; Chugh et al., 2001). It confers a
five- to six-fold increased risk for ischemic stroke (Romero and
Wolf, 2013). The prevalence of AF increases substantially with
advancing age (Kannel et al., 1998). Aging is the most important
non-modifiable risk factor for stroke (Murray and Lopez, 1997;
Lloyd-Jones et al., 2009). Moreover, older patients reportedly
have poor functional outcomes after stroke (Palnum et al., 2008;
Saposnik et al., 2008; Fonarow et al., 2010; Soares et al., 2011;
Deng et al., 2012). Although there is a low prevalence of AF in
China, the disease burden of AF-related stroke is great due to
the aging population. It is predicted that the number of people
aged >60 years worldwide is estimated to increase to 1.2 billion
by 2025, double the number of people who were in this age group
in 1995 (Krug et al., 2002). The number of people aged≥65 years
in China was 200 million in 2014 (Peilin et al., 2014), and 3.5%
of the population was≥75 years old in 2013 (National Bureaus of
Statistics of the People’s Republic of China, 2014). Thus, with the
aging of the worldwide population, stroke has become a major
public health problem.
Stroke patients with AF have been reported to have higher
mortality compared to stroke patients without AF, with rates
between 30.5 and 63.0% at 12 months after stroke (Kolominsky-
Rabas et al., 2001; Roquer et al., 2003; Banks and Marotta,
2007; Saposnik et al., 2008). In addition, worse neurological
function has been reported in stroke patients with AF (Stuart-
Shor et al., 2009). However, long-term outcomes after stroke in
elderly patients with AF are uncertain in China.
Therefore, in this study, we aimed to compare differences
in long-term outcomes, including mortality, dependency, and
recurrence rates after stroke, between elderly stroke patients with
AF and those without AF.
MATERIALS AND METHODS
This study used data from a stroke registry in the Department
of Neurology, Jiamusi University First Hospital, China; the
inclusion criteria for stroke patients have been described in
a previous study (Wu et al., 2015). Briefly, we prospectively
collected data on the clinical characteristics and outcomes for all
Abbreviations: AF, atrial fibrillation; BI, Barthel Index; CI, confidence interval;
DM, diabetes mellitus; HbA1c, glycosylated hemoglobin; HDL-C, high-density
lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; mRS,
modified Rankin scale; NIHSS, National Institutes of Health Stroke Scale; OR, odds
ratio; TC, total cholesterol; TG, triglycerides.
ischemic stroke patients who were admitted to the Department
of Neurology, Jiamusi University First Hospital, China between
January 2008 and December 2013. Stroke events were defined
according to the World Health Organization’s criteria, and all
cases of stroke were confirmed by neuroimaging (1989). Patients
with transient ischemic attack were excluded from this study,
and all stroke patients aged 75 years and over were included.
AF was defined as a history of AF, confirmed by at least
one electrocardiogram or the presence of arrhythmia during
hospitalization.
The ethics committee of Jiamusi University First Hospital
approved the study, and written informed consent was obtained
from all patients or their next-of-kin.
Data collection and outcome evaluation were performed by
senior neurologists who used standardized variable definitions
and scores. Stroke subtypes, which were classified on admission,
included total anterior circulation infarcts, partial anterior
circulation infarcts, lacunar infarcts, and posterior circulation
infarcts, according to Oxfordshire Community Stroke Project
criteria (Bamford et al., 1991). Stroke severity was categorized
into three groups according to National Institutes of Health
Stroke Scale (NIHSS) scores: mild (NIHSS score: ≤7), moderate
(NIHSS score: 8–16), and severe (NIHSS score: ≥17) (Kim et al.,
2010). Receiving oral anticoagulants was defined as receiving
oral anticoagulants before stroke onset. General stroke risk
factors, including hypertension, diabetes mellitus (DM), and
hyperlipidemia, were defined according to self-reported previous
medical history, and obesity was defined as a body mass index
≥30 kg/m2. The NIHSS score and Barthel Index (BI) were
evaluated on admission and at discharge; the modified Rankin
Scale (mRS) score was assessed on admission, at discharge, and
at 3 and 12 months after stroke.
Outcomes included mortality, dependency, and recurrence
rates at 3 and 12 months after stroke. Mortality was defined as
all-cause cumulative death at the corresponding follow-up time
point. Stroke recurrence was defined as all new-onset vascular
events, including stroke, myocardial infarction, and venous
thrombosis. Dependency was defined as anmRS score>2 (Banks
and Marotta, 2007). Follow-up was implemented according to a
predetermined procedure; the same senior neurologist collected
data at 1 year and 3 years after stroke. Follow-up occurred for
all patients in a face-to-face interview, except for those patients
who were re-examined in their local hospitals, who completed
follow-up by telephone.
Patients were divided into two groups—those with AF (the
AF group) and those without AF (the non-AF group)—and data
were compared between the two groups. Continuous variables,
including age, NIHSS score, BI, mRS score, total cholesterol
(TC), triglycerides (TG), high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting
glucose, and glycosylated hemoglobin (HbA1c), were presented
as means with standard deviations (or as medians with ranges
where appropriate) and were compared between groups using
the Student t-test or the Mann-Whitney U test. Dichotomous
variables, including stroke severity, stroke risk factors, and
outcomes during follow-up after stroke, were presented as
number of cases (percentages); the risk factors were compared
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between groups with the chi-squared test. The relationship
between AF and outcomes was assessed with logistic regression
analyses and presented as unadjusted odds ratios (ORs) with 95%
confidence intervals (CIs). A multivariate analysis between age
and outcomes was carried out with a logistic regression analysis,
with covariates of stroke severity, previous medical history, and
risk factors, and were presented using adjusted ORs with 95%
CIs. All statistical analyses were performed using SPSS version
15.0 (SPSS Inc., Chicago, IL), and a two-tailed p < 0.05 indicated
statistical significance.
RESULTS
A total of 4922 patients experienced acute ischemic stroke
and were hospitalized during the study period; of these, there
were1070 patients aged ≥75 years. Outcomes at 1 year post-
stroke were available for 867 elderly stroke patients (93.2%), after
excluding 63 patients lost to follow-up, and outcomes at 3 years
post-stroke were available for 453 elderly stroke patients (91.5%),
after excluding 42 patients lost to follow-up (Figure 1).
Overall, 1070 elderly stroke patients were included in this
study (172 in the AF group and 898 in the non-AF group);
the prevalence of AF was 16.1% overall; similar for men and
women (15.0 vs. 17.5%, P = 0.256). The AF group was more
likely than the non-AF group to have severe stroke (32.0 vs.
11.9%, P < 0.001), and they had worse neurological function
(i.e., they had higher mRS scores but lower BI scores). The
levels of TC, TG, HDL-C, LDL-C, fasting glucose, and HbA1c
were not significantly different between the two groups. There
were no obvious differences in the prevalence of hypertension,
DM, dyslipidemia, obesity, and current smoking between the
two groups, but there was a higher prevalence of diabetes in the
non-AF group (Table 1).
Mortality was significantly higher in the AF group than in
the non-AF group at 1 year after stroke (29.6 vs. 17.8%, P =
0.010) and at 3 years after stroke (46.1 vs. 33.2%, P = 0.032),
respectively. Similar trends were found for the dependency (49.5
vs. 36.1% at 1 year after stroke and 70.7 vs. 49.2% at 3 years
after stroke (all P < 0.001). However, there were no significant
differences in recurrence rates between the two groups across
the follow-up periods. The results for dependency remained
stable after adjustment for sex, stroke severity, and stroke risk
factors at 3 years after stroke (OR, 2.26; 95% CI, 1.06–4.81; P
= 0.034); however, the relationship between AF and mortality
and recurrence disappeared after adjusting for these covariates
(Table 2).
DISCUSSION
To our knowledge, this is the first report of the effects of AF on
outcomes among elderly stroke patients in China. In this study,
we compared the differences in clinical features, conventional
stroke risk factors, and outcomes at 1 year and 3 years after stroke
among elderly stroke patients with and without AF.
A previous study indicated that, compared to stroke patients
without AF, those with AF were less likely to have conventional
risk factors for stroke (including hypertension, DM, current
smoking, and alcohol consumption Sun et al., 2015), were
slightly more likely to experience a recurrent ischemic stroke or
intracranial hemorrhage within 2 weeks, and were more than
twice as likely to die within 2 weeks to 6 months (Mattle, 2003).
Consistent with these studies, there was a higher frequency of
severe stroke, and worse neurological function in the AF group
than in the non-AF group in this study.
Regarding risk factors for stroke in patients with AF,
conclusions are widely divergent due to the different study
designs used. The previous study indicated that stroke patients
with AF were less likely to have the conventional risk factors
for stroke, including hypertension, diabetes mellitus, current
smoking, and alcohol consumption habits (Lamassa et al., 2001;
FIGURE 1 | Flow diagram of participants.
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Mizrahi et al., 2014), but significant differences in the frequency
of conventional stroke risk factors were reported in others
(Andrew et al., 2014). In the present study, the prevalence
TABLE 1 | The clinical features and previous history of diseases in elderly
ischemic stroke patients by AF.
Characteristics AF group non-AF group P
Cases, n (%) 172 (16.1) 898 (83.9) –
TOAST classification, n (%): <0.001
Atherothrombotic 68 (39.5) 655 (72.9)
Small artery disease 91 (52.9) 207 (23.1)
Cardiac embolism 12 (7.0) 21 (2.3)
Others determined etiology 1 (0.6) 6 (0.7)
Undetermined etiology 0 9 (1.0)
OCSP classification, n (%):
Total anterior circulation infarct 38 (22.1) 55 (6.1)
Partial anterior circulation infarct 91 (52.9) 514 (57.4)
Lacunar infarct 6 (3.5) 63 (7.0)
Posterior circulation infarct 37 (21.5) 264 (29.5)
Stroke severity, n (%): <0.001
Mild 70 (40.7) 527 (58.7)
Moderate 47 (27.3) 264 (29.4)
Severe 55 (32.0) 107 (11.9)
Neurological function:
BI 20 (100) 40 (100) <0.001
mRS 5 (5) 4 (6) <0.001
Receiving oral anticoagulants, n (%) 24 (14.0) 0 –
Laboratory examination:
Total cholesterol 4.78 (1.20) 4.83 (1.09) 0.600
Triglyceride 1.20 (0.99) 1.31 (0.89) 0.156
High density lipoprotein cholesterol 1.16 (0.29) 1.12 (0.61) 0.427
Low density lipoprotein cholesterol 2.95 (0.98) 2.99 (0.88) 0.615
Fasting glucose 6.66 (3.16) 6.49 (2.44) 0.489
Glycosylated hemoglobin 6.27 (1.27) 6.55 (1.25) 0.069
Hypertension 117 (68.0) 663 (73.8) 0.116
Diabetes 35 (20.3) 270 (30.1) 0.010
Dyslipidemias 37 (21.5) 209 (23.3) 0.615
Obesity 23 (13.4) 123 (13.7) 0.909
Current smoking 35 (20.3) 200 (22.3) 0.577
Alcohol consumption 7 (4.1) 71 (7.9) 0.076
of hypertension, dyslipidemia, obesity, current smoking, and
alcohol consumption was not significantly different between the
two groups, but there was a higher frequency of diabetes in the
non-AF group, as reported in the prior study (Lamassa et al.,
2001; Mizrahi et al., 2014).
Previous studies have demonstrated that elderly stroke
patients were more likely, compared to younger stroke patients,
to have poor outcomes after acute ischemic stroke, including
increased short-term and long-term mortality rates, dependency
rates, and a higher risk of stroke recurrence (Johnston et al., 2002;
Kammersgaard et al., 2004; Marini et al., 2004; Rothwell et al.,
2005; Palnum et al., 2008; Fonarow et al., 2010; Romero and
Wolf, 2013). Elderly acute ischemic stroke patients have poorer
outcomes overall (Candelise et al., 1991), these are associated
with an enhanced susceptibility to the secondary degeneration
in the primary ischemic lesion (Loubinoux et al., 2012). Stroke
patients are at highest risk of death in the first weeks after
the event, and between 20 and 50% die within the first month
depending on type, severity, age, co-morbidity and effectiveness
of treatment of complications. Patients who survive may be
following with no disability or with mild, moderate or severe
disability. However, patients with a history of stroke are at risk
of a subsequent event of around 10% in the first year and 5%
per year thereafter (Sandu et al., 2015). Moreover, vascular risk
factors, including hypertension, obesity, diabetes, dyslipidaemia,
hyperhomocystaeinemia, and systemic inflammation increase
the probability of silent strokes (Burn et al., 1994).
Findings related to the effects of AF on outcomes in stroke
patients have been inconsistent, but most previous studies
have reported that AF is associated with higher mortality rates
(Candelise et al., 1991; Gustaffson and Britton, 1991; Jørgensen
et al., 1996; Lin et al., 1996). A few studies indicated a higher
recurrence rate in stroke patients with AF (Sandercock et al.,
1992; Lin et al., 1996) and a markedly increased dependency
(Karatas¸ et al., 2000). In the present study, we found that there
was higher rate of dependency among elderly patients with AF at
3 years after stroke. However, in contrast to previous reports, we
found no differences in mortality and recurrence rates between
the groups at 1 year and 3 years after stroke. The higher frequency
of severe stroke may contribute to the higher rate of dependency
among elderly stroke patients with AF, but similar rates of
mortality and recurrence among elderly stroke patients across AF
TABLE 2 | The outcomes and OR at 1 year and 3 years after stroke among elderly stroke patients by AF.
Outcomes AF group non-AF group Univariate analysis Multivariate analysis
OR (95%CI) P OR (95%CI) P
1 YEAR
Mortality 42 (29.6) 129 (17.8) 1.66 (1.23–2.24) 0.001 1.06 (0.79–2.00) 0.335
Dependency 50 (49.5) 216 (36.1) 1.37 (1.10–1.72) 0.010 1.36 (0.86–2.16) 0.187
Recurrence 40 (32.3) 162 (24.1) 1.34 (1.01–1.79) 0.054 1.35 (0.88–2.08) 0.171
3 YEARS
Mortality 35 (46.1) 125 (33.2) 1.39 (1.05–1.84) 0.032 1.28 (0.73–2.23) 0.386
Dependency 29 (70.7) 125 (49.2) 1.44 (1.14–1.82) 0.010 2.26 (1.06–4.81) 0.034
Recurrence 33 (48.5) 158 (45.5) 1.07 (0.81–1.40) 0.650 1.09 (0.63–1.87) 0.767
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groups may be a result of older age (Karatas¸ et al., 2000), and
similar frequency of conventional stroke risk factors between the
AF group and the non-AF group may partly explain the identical
rates of mortality and recurrence among elderly patients (Sandu
et al., 2015).
The limitation of this study is that it was a hospital-based
study, which might not reflect the general population in China.
Furthermore, patients for whom the stroke was fatal, i.e., who
died before being hospitalized, were not included in this study.
Therefore, there was a relatively low prevalence of AF in this
study.
CONCLUSION
In this single-hospital-based stroke registry, we compared
differences in clinical features, risk factors, and outcomes at 1
year and 3 years post-stroke among elderly stroke patients with
and without AF. There was a higher frequency of severe stroke in
the AF group than in the non-AF group. While the prevalence
of hypertension, dyslipidemia, obesity, current smoking, and
alcohol consumption was not obviously different between the two
groups, there was a higher frequency of DM in the non-AF group.
There was a significantly higher dependency rate at 3 years after
stroke in the AF group, but not in mortality rates or recurrence
rates across the follow-up periods. These findings suggest that it is
crucial to highlight the treatment of elderly stroke patients with
AF in order to reduce poor outcomes among the elderly and to
reduce the burden of AF in China.
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